Registration
CARA REGISTRASI
Pilih sesi dan tanggal yang diminati --> Pilih tautan "Click to Register" --> Isi data diri anda
(Data akan digunakan untuk pembuatan dan pengiriman e-sertifikat)
JADWAL WEBINAR
|
Sesi |
Hari/tanggal |
Waktu |
Topik |
Pembicara dan Moderator |
|
1 |
Sabtu, 6 Juni 2020 Telah Terlaksana |
10.00 – 12.00 |
High Bleeding Risk in PCI : Translating Latest Clinical Data into Practice |
Prof. Dr. dr. Idrus Alwi, SpPD-KKV, FINASIM, FACC, FESC, FAPSIC, FACP |
|
PCI in Covid-19 Pandemic Era |
Dr. dr. Eka Ginanjar, SpPD, KKV, FINASIM, FACP, FICA |
|||
|
2 |
Sabtu, 6 Juni 2020 Telah Terlaksana |
13.00 – 15.00 |
Thrombosis state in COVID-19 and the role of anticoagulant to improve patient prognosis |
dr. Nadia Ayu Mulansari, SpPD-KHOM |
|
Case Management of ACS STEMI in Covid-19 patients |
Dr. dr. Eka Ginanjar, SpPD-KKV, FINASIM, FACP, FICA |
|||
|
|
Moderator : Dr. dr. Sally Aman Nasution, SpPD,K-KV, FINASIM, FACP |
|||
|
3 |
Sabtu, 13 Juni 2020 Telah Terlaksana |
10.00 – 12.00 |
Optimizing outcome of pulmonary arterial hypertension |
|
|
Updates on Pulmonary Hypertension: what current evidence recommend. |
dr. Dono Antono, SpPD-KKV, FINASIM, FICA |
|||
|
Understanding the role of Sildenafil in PAH management. |
Dr. dr. Muhammad Yamin, SpJP(K), FACC, FSCAI |
|||
|
|
Moderator: dr. Lusiani, SpPD-KKV, FINASIM |
|||
|
4 |
Sabtu, 13 Juni 2020 Telah Terlaksana |
13.00 – 15.00 |
Update guideline on cardiovascular : how to treat in COVID-19 |
|
|
Treating covid-19 patients with CV disease focus on ACS STEMI |
Dr. dr. Sally Aman Nasution, SpPD,K-KV, FINASIM, FACP |
|||
|
Thrombosis vs bleeding risk of P2Y12 inhibitor use in Asian patients |
Prof. Dr. dr. Idrus Alwi, SpPD-KKV, FINASIM, FACC, FESC, FAPSIC, FACP |
|||
|
|
Moderator: Prof. dr. Ali Ghanie, SpPD-KKV, FINASIM |
|||
|
5 |
Sabtu, 20 Juni 2020 Telah Terlaksana |
10.00 – 12.00 |
Management of vascular disease |
|
|
Vascular Complication in Diabetes Patient |
dr. Dono Antono, Sp.PD-KKV, FINASIM, FICA |
|||
|
Aortic Aneurysm : A New Silent Killer |
dr. Birry Karim, SpPD, KKV, FINASIM, FICA |
|||
|
|
Moderator: dr. Ika Prasetya Wijaya, Sp.PD-KKV, FINASIM, FACP, FICA |
|||
|
6 |
Selasa, 23 Juni 2020 Telah Terlaksana
|
12.00 – 14.00 |
Echocardiography in the Time of COVID-19 |
|
|
Frontline Clinical and Operational Considerations in an Echo Department During and After COVID-19 |
Teresa Lopex Fernandez, MD |
|||
|
Recommendation for Echocardiography Laboratories: Utilization and Appropriateness of Echocardiography in Response to the COVID-19 Pandemic |
Sally Aman Nasution, MD |
|||
|
|
Moderator: Lusiani, MD |
|||
| 7 |
Rabu, 24 Juni 2020 Telah Terlaksana |
13.00 – 15.00 |
Current Guideline Review for Antihypertension and Anticoagulant |
|
|
The Role of Non Dihidropiridine CCB for Hypertension Management in Daily Practice : Current Guideline Review |
Dr. dr. Sally Aman Nasution, SpPD, K-KV, FINASIM, FACP |
|||
|
Optimalization use of Anticoagulant in ACS : Current Guideline Review |
dr. Ika Prasetya Wijaya, Sp.PD-KKV, FINASIM, FACP, FICA |
|||
|
|
Moderator: dr. Arif Masjoer, SpPD-KKV, KIC, M. Epid, FINASIM |
|||
|
8 |
Sabtu, 27 Juni 2020 Telah Terlaksana |
10.00 – 12.00 |
Optimizing CV Risk Assesment in High Risk Patients: When & How? |
|
|
CV Risk Assessment in Daily Practice: Any Difference Primary Intervention vs ASCVD Patients? |
dr. Muhadi, SpPD-KKV, M. Epid, FINASIM |
|||
|
High Intensity Statins in CVD: Translating Established & New Evidence Into Clinical Practice |
Dr. dr. Sally Aman Nasution, SpPD,K-KV, FINASIM, FACP |
|||
|
|
Moderator: dr. Moh. Syahrir Azizi, SpPD-KKV, FICA |
|||
|
9 |
Sabtu, 4 Juli 2020 Telah Terlaksana |
10.00 – 12.00 |
Management of Arrhythmia |
|
|
Why do heart failure patients need a pacemaker? |
Dr. dr. Muhammad Yamin, SpJP (K), FACC, FSCAI |
|||
|
When to put a pacemaker in bradycardia patient? |
dr. Simon Salim, Sp.PD-KKV, FINASIM, FACP, FICA, AIFO, M.Kes |
|||
|
10 |
Sabtu, 11 Juli 2020 Telah Terlaksana |
10.00 – 12.00 |
The Importance of Dyslipidemia Management in Special Population |
|
|
Managing Dyslipidemia in ACS Patients : How & What to do? |
Dr. dr. Eka Ginanjar, SpPD, KKV, FINASIM, FACP, FICA, MARS |
|||
|
Hidden Faces of Diabetes: Role of Lipid Management in CVD Preventions |
Dr. dr. Dyah Purnamasari, SpPD-KEMD |
|||
|
Targeting CV Risk in Patients with CKD Based on New Guidelines |
Dr. Aida Lidya, SpPD-KGH, PhD |
|||
|
|
Moderator: dr. Moh. Syahrir Azizi, SpPD-KKV, FICA |
|||
|
3 |
Sabtu, 11 Juli 2020 Telah Terlaksana |
13.00 – 15.00 |
Paradigm Changes in Angina Management |
|
|
Optimal medical therapy in angina management: a new hope? |
Prof. Dr. dr. Idrus Alwi, SpPD-KKV, FINASIM, FACC, FESC, FAPSIC, FACP |
|||
|
Treating Angina in different patients population |
Dr. dr. Muhammad Yamin, SpJP(K), FACC, FSCAI |
|||
|
|
Moderator: dr. Ika Prasetya Wijaya, Sp.PD-KKV, FINASIM, FACP, FICA |
|||
|
11 |
Sabtu, 18 Juli 2020 Telah Terlaksana |
10.00 – 12.00 |
TAVI : What and Why You Should Know |
|
|
General Introduction for TAVI |
dr. Birry Karim, SpPD, KKV, FINASIM, FICA |
|||
|
TAVI : State of The Art Case Sharing : PCI and TAVI in a High PCI RIsk/High Surgical Risk Case with Acute Coronary Syndrome |
Prof. Dr. dr. T. Santoso, Sp.PD-KKV,Sp.JP, Ph.D, FACC, FESC |
|||
|
12 |
Sabtu, 25 Juli 2020 Telah Terlaksana |
10.00 – 12.00 |
HF Treatment to minimize hospitalitation in new normal era |
|
|
ARNI in HFrEF Patient |
Prof. Dr. dr. Idrus Alwi, SpPD-KKV, FINASIM, FACC, FESC, FAPSIC, FACP |
|||
|
Benefit of ARB treatment in hypertension and controversies during the corona pandemic |
Dr. dr. Eka Ginanjar, SpPD, KKV, FINASIM, FACP, FICA |
|||
|
|
Moderator: dr. Ika Prasetya Wijaya, Sp.PD-KKV, FINASIM, FACP, FICA |
|||
|
13 |
Sabtu, 25 Juli 2020 Telah Terlaksana |
13.00 15.00 |
OPTIMIZING Antiplatet therapy after PCI in High Bleeding Risk patients |
Prof. Dr. dr. Idrus Alwi, SpPD-KKV, FINASIM, FACC, FESC, FAPSIC, FACP |
|
14 |
Sabtu, 1 Agustus 2020 Telah Terlaksana |
10.00 – 12.00 |
Anticoagulant Therapy from COVID-19 Era to New Normal |
|
|
Management of AF Patients during COVID-19 era (disease awareness, INR monitoring, guideline update) |
Dr. dr. Muhammad Yamin, SpJP(K), FACC, FSCAI |
|||
|
Practical Management of SPAF Patients during COVID-19 (case study, sharing session) |
dr. Simon Salim, Sp.PD-KKV, FINASIM, FACP, FICA, AIFO, M.Kes |
|||
|
|
Moderator: dr. Muhadi, SpPD-KKV, M. Epid, FINASIM |
|||
|
15 |
Sabtu, 1 Agustus 2020 Telah Terlaksana |
13.00 – 15.00 |
Hypertension and Heart Failure Management in the Real World |
|
|
BENEFIT of real world data in Hypertension |
dr. Charles Limantoro, SpPD-KKV, FINASIM |
|||
|
Insight from Seniors Trial: Can we do more in heart failure patients? |
Prof. dr. Lukman Hakim Makmun, SpPD-KKV, FINASIM |
|||
|
|
Moderator: dr. Muhadi, SpPD-KKV, M. Epid, FINASIM |
|||
|
15 |
Sabtu, 8 Agustus 2020 Telah Terlaksana |
10.00 – 12.00 |
Latest Updates in Hypertension Management: From Guideline to Clinical Practice |
|
|
How to Maximize Hypertension Outcome: Adapting Guidelines into Clinical Practice |
dr. Maruhum Bonar Hasiholan Marbun, SpPD-KGH |
|||
|
CCB Role in Blood Pressure Variability: An Update |
Prof. Dr. dr. Idrus Alwi, SpPD-KKV, FINASIM, FACC, FESC, FAPSIC, FACP |
|||
|
|
Moderator: dr. Angga Pramudita, SpPD |
|||
|
16 |
Sabtu, 15 Agustus 2020 Telah Terlaksana |
10.00 – 12.00 |
Update hypertension management based on guideline |
dr. Zainal Safri, SpPD-KKV, SpJP(K) |
|
The important of 24 hours protection for hypertension patient cause not all CCB are equals |
dr. Ika Prasetya Wijaya, Sp.PD-KKV, FINASIM, FACP, FICA |
|||
|
|
Moderator: dr. Muhadi, SpPD-KKV, M. Epid, FINASIM |
|||
|
17 |
Sabtu, 22 Agustus 2020 Telah Terlaksana |
10.00 – 12.00 |
The Role of Oral Anticoagulant in Thrombosis and Stroke Prevention |
|
|
Management of patients with high risk of VTE in New Normal |
Dr. dr. Lugyanti Sukrisman, SpPD-KHOM |
|||
|
Managing AF Patients Beyond Stroke Prevention - Should We Care For The Kidneys |
Dr. dr. Sally Aman Nasution, SpPD, K-KV, FINASIM, FACP |
|||
|
|
Moderator: dr. Arif Mansjoer, SpPD-KKV, KIC, M. Epid, FINASIM |
|||
|
18 |
Sabtu, 22 Agustus 2020 Telah Terlaksana |
10.00 – 12.00 |
The Role of Oral Anticoagulant in Thrombosis and Stroke Prevention |
|
|
Management of patients with high risk of VTE in New Normal |
Dr. dr. Lugyanti Sukrisman, SpPD-KHOM |
|||
|
Managing AF Patients Beyond Stroke Prevention - Should We Care For The Kidneys |
Dr. dr. Sally Aman Nasution, SpPD, K-KV, FINASIM, FACP |
|||
|
|
Moderator: dr. Arif Mansjoer, SpPD-KKV, KIC, M. Epid, FINASIM |
|||
|
19 |
Sabtu, 22 Agustus 2020 Telah Terlaksana |
10.00 – 12.00 |
The Role of Oral Anticoagulant in Thrombosis and Stroke Prevention |
|
|
Management of patients with high risk of VTE in New Normal |
Dr. dr. Lugyanti Sukrisman, SpPD-KHOM |
|||
|
Managing AF Patients Beyond Stroke Prevention - Should We Care For The Kidneys |
Dr. dr. Sally Aman Nasution, SpPD, K-KV, FINASIM, FACP |
|||
|
|
Moderator: dr. Arif Mansjoer, SpPD-KKV, KIC, M. Epid, FINASIM |
|||
|
20 |
Sabtu, 22 Agustus 2020 Telah Terlaksana |
10.00 – 12.00 |
The Role of Oral Anticoagulant in Thrombosis and Stroke Prevention |
|
|
Management of patients with high risk of VTE in New Normal |
Dr. dr. Lugyanti Sukrisman, SpPD-KHOM |
|||
|
Managing AF Patients Beyond Stroke Prevention - Should We Care For The Kidneys |
Dr. dr. Sally Aman Nasution, SpPD, K-KV, FINASIM, FACP |
|||
|
|
Moderator: dr. Arif Mansjoer, SpPD-KKV, KIC, M. Epid, FINASIM |
|||
|
21 |
Sabtu, 29 Agustus 2020 Telah Terlaksana |
10.00 – 12.00 |
Clinical Updates on Statin and Antiplatelet: What’s new? |
|
|
Statin Role in Managing ACS & CCS, Highlights from the Newest Guidelines |
Prof. Dr. dr. Idrus Alwi, SpPD-KKV, FINASIM, FACC, FESC, FAPSIC, FACP |
|||
|
High platelet reactivity in NSTEMI Diabetes : How to Manage? |
Prof. Dr. dr. T. Santoso, Sp.PD-KKV,Sp.JP, Ph.D, FACC, FESC |
|||
|
|
Moderator: dr. Marulam Panggabean, SpPD-KKV, SpJP, FINASIM |
|||
|
22 |
Sabtu, 5 September 2020 Telah Terlaksana |
10.00 – 12.00 |
The Unexpected Legacy of T2D CVOTs |
|
|
Evolving insights from EMPA REG OUTCOME and Beyond |
Dr. dr. Tri Juli Edi Tarigan, SpPD-KEMD, FINASIM |
|||
|
Diabetes and Heart Failure: Where new evidence can lead us? |
Prof. Dr. dr. Idrus Alwi, SpPD-KKV, FINASIM, FACC, FESC, FAPSIC, FACP |
|||
|
|
Moderator: dr. Ika Prasetya Wijaya, SpPD-KKV, FINASIM, FACP, FICA |
|||
|
23 |
Sabtu, 12 September 2020 Telah terlaksana |
10.00 – 12.00 |
Preventing CardioRenal Complication in T2D, The Current Management |
|
|
SGLT2i Efficacy: Consideration for T2DM Patients |
dr. Ida Ayu, SpPD-KEMD, FINASIM |
|||
|
How to Prevent Cardiovascular Complication in T2DM Patients: Insight from DECLARE TIMI-58 |
Prof. Dr. dr. Idrus Alwi, SpPD-KKV, FINASIM, FACC, FESC, FAPSIC, FACP |
|||
|
|
Moderator: dr. Ika Prasetya Wijaya, SpPD-KKV, FINASIM, FACP, FICA |
|||
|
24 |
Sabtu, 10 Oktober 2020 |
10.00 – 12.00 |
New evidence of SGLT2 inhibitor: Translating the science to clinical approach |
|
|
Looking at Endocrinologist experience |
dr. Wismandari Wisnu, SpPD-KEMD, FINASIM |
|||
|
From cardiologist perspective |
dr. Marulam Panggabean, SpPD-KKV, SpJP, FINASIM |
|||
|
|
Moderator: dr. Birry Karim, SpPD, KKV, FINASIM, FICA |
|||
Registration Fee:
All webinars are free of charge.
SKP IDI:
Elligible participants will be accredited 2 SKP IDI sent as e-Certificate by e-mail.